Investment
Features
FeesSafety
Academy
More
Pluang+

Purepoint Uranium reports strong radioactivity in summer drilling at Dorado's Nova Discovery, assays pending.

Market News
30 Jul 2026
Newsfile Corp
View Source
Bullish
pluang ai news

Purepoint Uranium Group announced results from the first phase of its 2026 summer drilling program at the Dorado Project in Saskatchewan, Canada. The highlight was drill hole NV26-11 at the Nova Discovery, which intersected 5.6 meters of continuous radioactivity averaging 11,730 counts per second, indicating high-grade uranium mineralization. These results support the geological model and will guide further drilling after a scheduled break, with laboratory assays still pending. The Dorado Project is a joint venture with IsoEnergy, focusing on expanding the known mineralized corridor and understanding the uranium system's geometry and continuity.

More News

AXT, Inc. expects nearly 90% revenue growth driven by AI demand and $100M indium phosphide backlog.

AXT, Inc. expects nearly 90% revenue growth driven by AI demand and $100M indium phosphide backlog.

AXT, Inc. has secured a long-term supply deal with Lumentum Holdings, reinforcing its role in providing indium phosphide wafers for advanced tech products. The company projects a nearly 90% revenue increase, fueled by strong demand from the AI sector...

Company Fundamentals
Bullish
52 minutes ago
Sanofi releases its half-year 2026 financial report and updates on business growth and pipeline progress.

Sanofi releases its half-year 2026 financial report and updates on business growth and pipeline progress.

Sanofi has published its half-year financial report for the period ending June 30, 2026, available on its website and filed with regulatory authorities in France and the US. The report highlights Sanofi's strong business performance, including double...

Company Fundamentals
Bullish
1 hour ago
Sanofi releases its half-year 2026 financial report and updates on business progress.

Sanofi releases its half-year 2026 financial report and updates on business progress.

Sanofi has published its financial report for the first half of 2026, available on its website and filed with the French financial authority (AMF). The biopharmaceutical company highlights its innovation in R&D and use of AI to drive long-term growth...

Company Fundamentals
Neutral
1 hour ago
Humana's stock target raised to $390 amid mixed analyst views and steady 2026 outlook

Humana's stock target raised to $390 amid mixed analyst views and steady 2026 outlook

Robert W. Baird raised Humana's stock price target to $390 from $205, signaling potential upside despite a 5.87% stock drop on a turbulent market day. Meanwhile, Raymond James downgraded Humana to Market Perform, indicating expected performance in li...

Company Fundamentals
Neutral
1 hour ago
Evercore ISI raises Teradyne price target to $420 on strong AI-driven revenue growth.

Evercore ISI raises Teradyne price target to $420 on strong AI-driven revenue growth.

Evercore ISI has increased its price target for Teradyne to $420 from $370, maintaining an Outperform rating due to the company's robust AI-driven growth. Teradyne reported record Q2 revenues of $1.33 billion, a 103.9% increase year-over-year, and no...

Analyst Insights
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App